annual net income:
-$99.56M-$141.51M(-337.30%)Summary
- As of today (September 17, 2025), PCRX annual net profit is -$99.56 million, with the most recent change of -$141.51 million (-337.30%) on December 31, 2024.
- During the last 3 years, PCRX annual net income has fallen by -$141.54 million (-337.16%).
- PCRX annual net income is now -168.42% below its all-time high of $145.52 million, reached on December 31, 2020.
Performance
PCRX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$4.85M-$9.66M(-200.73%)Summary
- As of today (September 17, 2025), PCRX quarterly net profit is -$4.85 million, with the most recent change of -$9.66 million (-200.73%) on June 30, 2025.
- Over the past year, PCRX quarterly net income has dropped by -$23.73 million (-125.66%).
- PCRX quarterly net income is now -103.73% below its all-time high of $130.12 million, reached on September 30, 2020.
Performance
PCRX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$127.46M-$23.73M(-22.88%)Summary
- As of today (September 17, 2025), PCRX TTM net profit is -$127.46 million, with the most recent change of -$23.73 million (-22.88%) on June 30, 2025.
- Over the past year, PCRX TTM net income has dropped by -$191.05 million (-300.43%).
- PCRX TTM net income is now -173.22% below its all-time high of $174.08 million, reached on June 30, 2021.
Performance
PCRX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PCRX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -337.3% | -125.7% | -300.4% |
| 3 y3 years | -337.2% | -124.4% | -424.9% |
| 5 y5 years | -803.8% | +33.3% | -1163.9% |
PCRX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -337.2% | at low | -118.8% | +96.6% | -280.9% | at low |
| 5 y | 5-year | -168.4% | at low | -103.7% | +96.6% | -173.2% | at low |
| alltime | all time | -168.4% | at low | -103.7% | +96.6% | -173.2% | at low |
PCRX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$4.85M(-200.7%) | -$127.46M(+22.9%) |
| Mar 2025 | - | $4.81M(-70.0%) | -$103.73M(+4.2%) |
| Dec 2024 | -$99.56M(-337.3%) | $16.04M(-111.2%) | -$99.56M(+9.7%) |
| Sep 2024 | - | -$143.47M(-859.6%) | -$90.73M(-242.7%) |
| Jun 2024 | - | $18.89M(+110.3%) | $63.59M(-9.8%) |
| Mar 2024 | - | $8.98M(-63.9%) | $70.47M(+68.0%) |
| Dec 2023 | $41.95M(+163.7%) | $24.87M(+129.0%) | $41.95M(+500.8%) |
| Sep 2023 | - | $10.86M(-57.9%) | $6.98M(-252.9%) |
| Jun 2023 | - | $25.76M(-231.9%) | -$4.57M(-56.3%) |
| Mar 2023 | - | -$19.54M(+93.4%) | -$10.46M(-165.7%) |
| Dec 2022 | $15.91M(-62.1%) | -$10.10M(+1357.7%) | $15.91M(-23.8%) |
| Sep 2022 | - | -$693.00K(-103.5%) | $20.88M(-46.8%) |
| Jun 2022 | - | $19.88M(+191.1%) | $39.23M(+2.1%) |
| Mar 2022 | - | $6.83M(-233.1%) | $38.44M(-8.4%) |
| Dec 2021 | $41.98M(-71.2%) | -$5.13M(-129.0%) | $41.98M(-31.9%) |
| Sep 2021 | - | $17.66M(-7.4%) | $61.62M(-64.6%) |
| Jun 2021 | - | $19.08M(+84.0%) | $174.08M(+17.8%) |
| Mar 2021 | - | $10.37M(-28.6%) | $147.73M(+1.5%) |
| Dec 2020 | $145.52M(-1421.0%) | $14.51M(-88.8%) | $145.52M(+15.4%) |
| Sep 2020 | - | $130.12M(-1890.1%) | $126.12M(-1350.6%) |
| Jun 2020 | - | -$7.27M(-189.1%) | -$10.09M(>+9900.0%) |
| Mar 2020 | - | $8.16M(-266.9%) | -$86.00K(-99.2%) |
| Dec 2019 | -$11.02M(+2238.9%) | -$4.89M(-19.7%) | -$11.02M(-610.7%) |
| Sep 2019 | - | -$6.09M(-323.0%) | $2.16M(-71.6%) |
| Jun 2019 | - | $2.73M(-198.5%) | $7.60M(+2.2%) |
| Mar 2019 | - | -$2.77M(-133.4%) | $7.44M(-1679.2%) |
| Dec 2018 | -$471.00K(-98.9%) | $8.29M(-1394.5%) | -$471.00K(-88.7%) |
| Sep 2018 | - | -$640.00K(-125.0%) | -$4.16M(-62.6%) |
| Jun 2018 | - | $2.56M(-124.0%) | -$11.12M(-66.7%) |
| Mar 2018 | - | -$10.68M(-332.4%) | -$33.42M(-21.6%) |
| Dec 2017 | -$42.61M | $4.59M(-160.5%) | -$42.61M(-16.7%) |
| Sep 2017 | - | -$7.60M(-61.5%) | -$51.18M(-22.2%) |
| Jun 2017 | - | -$19.74M(-0.6%) | -$65.75M(+21.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$19.87M(+400.0%) | -$53.96M(+42.2%) |
| Dec 2016 | -$37.95M(-2144.7%) | -$3.97M(-82.1%) | -$37.95M(+11.7%) |
| Sep 2016 | - | -$22.16M(+178.5%) | -$33.98M(+289.4%) |
| Jun 2016 | - | -$7.96M(+106.5%) | -$8.73M(+1048.2%) |
| Mar 2016 | - | -$3.85M(-224.9%) | -$760.00K(-107.5%) |
| Dec 2015 | $1.86M(-113.5%) | - | - |
| Sep 2015 | - | $3.09M(>+9900.0%) | $10.16M(+149.8%) |
| Jun 2015 | - | $8000.00(-99.4%) | $4.07M(-515.3%) |
| Mar 2015 | - | $1.26M(-78.3%) | -$979.00K(-92.9%) |
| Dec 2014 | -$13.72M(-78.5%) | $5.80M(-293.1%) | -$13.72M(-56.4%) |
| Sep 2014 | - | -$3.00M(-40.4%) | -$31.47M(-27.2%) |
| Jun 2014 | - | -$5.04M(-56.1%) | -$43.25M(-17.2%) |
| Mar 2014 | - | -$11.48M(-4.0%) | -$52.25M(-18.2%) |
| Dec 2013 | -$63.91M(+22.2%) | -$11.96M(-19.1%) | -$63.91M(-6.4%) |
| Sep 2013 | - | -$14.78M(+5.4%) | -$68.30M(-1.4%) |
| Jun 2013 | - | -$14.03M(-39.4%) | -$69.26M(+9.0%) |
| Mar 2013 | - | -$23.14M(+41.6%) | -$63.52M(+21.5%) |
| Dec 2012 | -$52.28M(+20.7%) | -$16.35M(+3.8%) | -$52.28M(+2.1%) |
| Sep 2012 | - | -$15.74M(+89.8%) | -$51.22M(+13.9%) |
| Jun 2012 | - | -$8.30M(-30.3%) | -$44.98M(-1.0%) |
| Mar 2012 | - | -$11.89M(-22.2%) | -$45.45M(+4.9%) |
| Dec 2011 | -$43.33M(+59.6%) | -$15.28M(+60.7%) | -$43.33M(+23.5%) |
| Sep 2011 | - | -$9.51M(+8.5%) | -$35.09M(-23.2%) |
| Jun 2011 | - | -$8.76M(-10.4%) | -$45.69M(+4.5%) |
| Mar 2011 | - | -$9.78M(+38.8%) | -$43.74M(+11.1%) |
| Dec 2010 | -$27.15M(-14.4%) | -$7.04M(-65.0%) | -$39.35M(-4.7%) |
| Sep 2010 | - | -$20.11M(+195.1%) | -$41.28M(+48.7%) |
| Jun 2010 | - | -$6.81M(+26.4%) | -$27.77M(+32.5%) |
| Mar 2010 | - | -$5.39M(-39.9%) | -$20.95M(+34.6%) |
| Dec 2009 | -$31.71M(-24.3%) | -$8.97M(+36.1%) | -$15.56M(+136.1%) |
| Sep 2009 | - | -$6.59M | -$6.59M |
| Dec 2008 | -$41.86M(+15.7%) | - | - |
| Dec 2007 | -$36.19M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual net profit?
- What is the all time high annual net income for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual net income year-on-year change?
- What is Pacira BioSciences, Inc. quarterly net profit?
- What is the all time high quarterly net income for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly net income year-on-year change?
- What is Pacira BioSciences, Inc. TTM net profit?
- What is the all time high TTM net income for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM net income year-on-year change?
What is Pacira BioSciences, Inc. annual net profit?
The current annual net income of PCRX is -$99.56M
What is the all time high annual net income for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual net profit is $145.52M
What is Pacira BioSciences, Inc. annual net income year-on-year change?
Over the past year, PCRX annual net profit has changed by -$141.51M (-337.30%)
What is Pacira BioSciences, Inc. quarterly net profit?
The current quarterly net income of PCRX is -$4.85M
What is the all time high quarterly net income for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly net profit is $130.12M
What is Pacira BioSciences, Inc. quarterly net income year-on-year change?
Over the past year, PCRX quarterly net profit has changed by -$23.73M (-125.66%)
What is Pacira BioSciences, Inc. TTM net profit?
The current TTM net income of PCRX is -$127.46M
What is the all time high TTM net income for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM net profit is $174.08M
What is Pacira BioSciences, Inc. TTM net income year-on-year change?
Over the past year, PCRX TTM net profit has changed by -$191.05M (-300.43%)